Calvary Mater Newcastle Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2024

  1. Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma

    European Urology Focus

2021

  1. Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World Practice

    The Journal of urology, Vol. 206, Núm. 2, pp. 240-251

2019

  1. Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract

    European Urology, Vol. 76, Núm. 1, pp. 73-81